Attached files
| file | filename |
|---|---|
| EX-99.1 - MARCH 27, 2012 NEWS RELEASE - ANAVEX LIFE SCIENCES CORP. | exhibit99-1.htm |
| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| FORM 8-K |
| CURRENT REPORT |
| Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 |
| Date of Report (Date of earliest event reported) March 27, 2012 |
| ANAVEX LIFE SCIENCES CORP. |
| (Exact name of registrant as specified in its charter) |
| Nevada | 000-51652 | 20-8365999 |
| (State or other jurisdiction | (Commission | (IRS Employer |
| of incorporation) | File Number) | Identification No.) |
| 45 Tintern Lane, Portola Valley, California 84028 |
| (Address of principal executive offices and Zip Code) |
| Registrant's telephone number, including area code 1-800-689-3939 |
| N/A |
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the FORM 8-K/A filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
2
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On March 27, 2012 we announced the resignation of Dr. George Tidmarsh from our board of directors. Dr. Tidmarsh’s resignation was not as a result of any disagreement with our company or its policies.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits |
| 99.1 | March 27, 2012 news release |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ANAVEX LIFE SCIENCES CORP. |
| /s/ Harvey Lalach |
| Harvey Lalach |
| President, Chief Operating Officer, Interim CFO and Director |
| Date: March 27, 2012 |